Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 58

1.

Muraminomicins, new lipo-nucleoside antibiotics from Streptosporangium sp. SANK 60501-structure elucidations of muraminomicins and supply of the core component for derivatization.

Fujita Y, Kagoshima Y, Masuda T, Kizuka M, Ogawa Y, Endo S, Nishigoori H, Saito K, Takasugi K, Miura M, Murakami R, Muramatsu Y, Tokumitsu A, Koga T, Iizuka M, Aoyagi A, Suzuki T, Suzuki T, Suzuki Y, Ishida O, Nakahira T, Miyakoshi S, Konosu T, Takatsu T.

J Antibiot (Tokyo). 2019 Aug 14. doi: 10.1038/s41429-019-0215-7. [Epub ahead of print]

PMID:
31413314
2.

Neuromuscular stimulation ameliorates ischemia-induced walking impairment in the rat claudication model.

Shiragaki-Ogitani M, Kono K, Nara F, Aoyagi A.

J Physiol Sci. 2019 Aug 6. doi: 10.1007/s12576-019-00701-9. [Epub ahead of print]

PMID:
31388976
3.

Aβ and tau prion-like activities decline with longevity in the Alzheimer's disease human brain.

Aoyagi A, Condello C, Stöhr J, Yue W, Rivera BM, Lee JC, Woerman AL, Halliday G, van Duinen S, Ingelsson M, Lannfelt L, Graff C, Bird TD, Keene CD, Seeley WW, DeGrado WF, Prusiner SB.

Sci Transl Med. 2019 May 1;11(490). pii: eaat8462. doi: 10.1126/scitranslmed.aat8462.

PMID:
31043574
4.

Relationship between oxygen cost and C-reactive protein response to marathon running in college recreational runners.

Takayama F, Aoyagi A, Takahashi K, Nabekura Y.

Open Access J Sports Med. 2018 Nov 27;9:261-268. doi: 10.2147/OAJSM.S183274. eCollection 2018.

5.

Familial Parkinson's point mutation abolishes multiple system atrophy prion replication.

Woerman AL, Kazmi SA, Patel S, Aoyagi A, Oehler A, Widjaja K, Mordes DA, Olson SH, Prusiner SB.

Proc Natl Acad Sci U S A. 2018 Jan 9;115(2):409-414. doi: 10.1073/pnas.1719369115. Epub 2017 Dec 26.

6.

Effects of Marathon Running on Aerobic Fitness and Performance in Recreational Runners One Week after a Race.

Takayama F, Aoyagi A, Shimazu W, Nabekura Y.

J Sports Med (Hindawi Publ Corp). 2017;2017:9402386. doi: 10.1155/2017/9402386. Epub 2017 Aug 24.

7.

MSA prions exhibit remarkable stability and resistance to inactivation.

Woerman AL, Kazmi SA, Patel S, Freyman Y, Oehler A, Aoyagi A, Mordes DA, Halliday GM, Middleton LT, Gentleman SM, Olson SH, Prusiner SB.

Acta Neuropathol. 2018 Jan;135(1):49-63. doi: 10.1007/s00401-017-1762-2. Epub 2017 Aug 28.

8.

α-Synuclein: Multiple System Atrophy Prions.

Woerman AL, Watts JC, Aoyagi A, Giles K, Middleton LT, Prusiner SB.

Cold Spring Harb Perspect Med. 2018 Jul 2;8(7). pii: a024588. doi: 10.1101/cshperspect.a024588. Review.

9.

Tau prions from Alzheimer's disease and chronic traumatic encephalopathy patients propagate in cultured cells.

Woerman AL, Aoyagi A, Patel S, Kazmi SA, Lobach I, Grinberg LT, McKee AC, Seeley WW, Olson SH, Prusiner SB.

Proc Natl Acad Sci U S A. 2016 Dec 13;113(50):E8187-E8196. Epub 2016 Nov 28.

10.

Propagation of prions causing synucleinopathies in cultured cells.

Woerman AL, Stöhr J, Aoyagi A, Rampersaud R, Krejciova Z, Watts JC, Ohyama T, Patel S, Widjaja K, Oehler A, Sanders DW, Diamond MI, Seeley WW, Middleton LT, Gentleman SM, Mordes DA, Südhof TC, Giles K, Prusiner SB.

Proc Natl Acad Sci U S A. 2015 Sep 1;112(35):E4949-58. doi: 10.1073/pnas.1513426112. Epub 2015 Aug 18.

11.

[Classification of nurse and caregiver evaluation criteria for activity care in elderly people with dementia].

Aoyagi A, Nishida M.

Nihon Ronen Igakkai Zasshi. 2014;51(3):264-70. Japanese.

12.

Genome degeneration and adaptation in a nascent stage of symbiosis.

Oakeson KF, Gil R, Clayton AL, Dunn DM, von Niederhausern AC, Hamil C, Aoyagi A, Duval B, Baca A, Silva FJ, Vallier A, Jackson DG, Latorre A, Weiss RB, Heddi A, Moya A, Dale C.

Genome Biol Evol. 2014 Jan;6(1):76-93. doi: 10.1093/gbe/evt210.

13.

Evidence-based path to newborn screening for Duchenne muscular dystrophy.

Mendell JR, Shilling C, Leslie ND, Flanigan KM, al-Dahhak R, Gastier-Foster J, Kneile K, Dunn DM, Duval B, Aoyagi A, Hamil C, Mahmoud M, Roush K, Bird L, Rankin C, Lilly H, Street N, Chandrasekar R, Weiss RB.

Ann Neurol. 2012 Mar;71(3):304-13. doi: 10.1002/ana.23528.

PMID:
22451200
14.

Successful detection of the fetal electrocardiogram waveform changes during various states of singletons.

Sato N, Hoshiai T, Ito T, Owada K, Chisaka H, Aoyagi A, Sugawara J, Yaegashi N, Okamura K, Kimura Y.

Tohoku J Exp Med. 2011 Oct;225(2):89-94.

15.

Mindbomb 1, an E3 ubiquitin ligase, forms a complex with RYK to activate Wnt/β-catenin signaling.

Berndt JD, Aoyagi A, Yang P, Anastas JN, Tang L, Moon RT.

J Cell Biol. 2011 Sep 5;194(5):737-50. doi: 10.1083/jcb.201107021. Epub 2011 Aug 29.

16.

Aberrant expression of hypoxia-inducible factor 1α in the fetal heart is associated with maternal undernutrition.

Ito T, Tanabe K, Nakamura A, Funamoto K, Aoyagi A, Sato K, Hoshiai T, Suenaga K, Sugawara J, Nagase S, Okamura K, Yaegashi N, Kimura Y.

Tohoku J Exp Med. 2011 Jul;224(3):163-71.

17.

Maternal undernutrition with vaginal inflammation impairs the neonatal oligodendrogenesis in mice.

Ito T, Hoshiai K, Tanabe K, Nakamura A, Funamoto K, Aoyagi A, Chisaka H, Okamura K, Yaegashi N, Kimura Y.

Tohoku J Exp Med. 2011 Mar;223(3):215-22.

18.

Channel models for wireless body area networks.

Takizawa K, Aoyagi A, Takada J, Katayama N, Yekeh K, Takehiko Y, Kohno KR.

Conf Proc IEEE Eng Med Biol Soc. 2008;2008:1549-52. doi: 10.1109/IEMBS.2008.4649465.

PMID:
19162968
19.

Colletoic acid, a novel 11beta-hydroxysteroid dehydrogenase type 1 inhibitor from Colletotrichum gloeosporioides SANK 21404.

Aoyagi A, Ito-Kobayashi M, Ono Y, Furukawa Y, Takahashi M, Muramatsu Y, Umetani M, Takatsu T.

J Antibiot (Tokyo). 2008 Mar;61(3):136-41. doi: 10.1038/ja.2008.122.

PMID:
18503191
20.

Sterenin A, B, C and D, novel 11beta-hydroxysteroid dehydrogenase type 1 inhibitors from Stereum sp. SANK 21205.

Ito-Kobayashi M, Aoyagi A, Tanaka I, Muramatsu Y, Umetani M, Takatsu T.

J Antibiot (Tokyo). 2008 Mar;61(3):128-35. doi: 10.1038/ja.2008.121.

PMID:
18503190
21.

Pleofungins, novel inositol phosphorylceramide synthase inhibitors, from Phoma sp. SANK 13899. II. Structural elucidation.

Aoyagi A, Yano T, Kozuma S, Takatsu T.

J Antibiot (Tokyo). 2007 Feb;60(2):143-52.

PMID:
17420565
22.

Pleofungins, novel inositol phosphorylceramide synthase inhibitors, from Phoma sp. SANK 13899. I. Taxonomy, fermentation, isolation, and biological activities.

Yano T, Aoyagi A, Kozuma S, Kawamura Y, Tanaka I, Suzuki Y, Takamatsu Y, Takatsu T, Inukai M.

J Antibiot (Tokyo). 2007 Feb;60(2):136-42.

PMID:
17420564
23.

A solid tumor of donor cell-origin after allogeneic peripheral blood stem cell transplantation.

Arai Y, Arai H, Aoyagi A, Yamagata T, Mitani K, Kubota K, Kawamata H, Imai Y.

Am J Transplant. 2006 Dec;6(12):3042-3. No abstract available.

24.

Improved molecular diagnosis of dystrophinopathies in an unselected clinical cohort.

Dent KM, Dunn DM, von Niederhausern AC, Aoyagi AT, Kerr L, Bromberg MB, Hart KJ, Tuohy T, White S, den Dunnen JT, Weiss RB, Flanigan KM.

Am J Med Genet A. 2005 Apr 30;134(3):295-8.

PMID:
15723292
25.

Automated genomic sequence analysis of the three collagen VI genes: applications to Ullrich congenital muscular dystrophy and Bethlem myopathy.

Lampe AK, Dunn DM, von Niederhausern AC, Hamil C, Aoyagi A, Laval SH, Marie SK, Chu ML, Swoboda K, Muntoni F, Bonnemann CG, Flanigan KM, Bushby KM, Weiss RB.

J Med Genet. 2005 Feb;42(2):108-20.

26.

Pharmacological characterization of RS-1259, an orally active dual inhibitor of acetylcholinesterase and serotonin transporter, in rodents: possible treatment of Alzheimer's disease.

Abe Y, Aoyagi A, Hara T, Abe K, Yamazaki R, Kumagae Y, Naruto S, Koyama K, Marumoto S, Tago K, Toda N, Takami K, Yamada N, Ori M, Kogen H, Kaneko T.

J Pharmacol Sci. 2003 Sep;93(1):95-105.

27.

A conformational restriction approach to the development of dual inhibitors of acetylcholinesterase and serotonin transporter as potential agents for Alzheimer's disease.

Toda N, Tago K, Marumoto S, Takami K, Ori M, Yamada N, Koyama K, Naruto S, Abe K, Yamazaki R, Hara T, Aoyagi A, Abe Y, Kaneko T, Kogen H.

Bioorg Med Chem. 2003 Oct 1;11(20):4389-415.

PMID:
13129577
28.

Design, synthesis and structure-activity relationships of dual inhibitors of acetylcholinesterase and serotonin transporter as potential agents for Alzheimer's disease.

Toda N, Tago K, Marumoto S, Takami K, Ori M, Yamada N, Koyama K, Naruto S, Abe K, Yamazaki R, Hara T, Aoyagi A, Abe Y, Kaneko T, Kogen H.

Bioorg Med Chem. 2003 May 1;11(9):1935-55.

PMID:
12670645
29.

Successful HLA-identical unrelated allogeneic bone marrow transplantation with a very low dose of stem cells for a patient with chronic myeloid leukemia in blast crisis.

Arai H, Arai Y, Haraguchi K, Nakamura Y, Tsurumi S, Maki K, Aoyagi A, Nakamura Y, Saito K, Mitani K.

Leuk Lymphoma. 2002 Oct;43(10):2067-9. No abstract available.

PMID:
12481912
30.

Design and synthesis of dual inhibitors of acetylcholinesterase and serotonin transporter targeting potential agents for Alzheimer's disease.

Kogen H, Toda N, Tago K, Marumoto S, Takami K, Ori M, Yamada N, Koyama K, Naruto S, Abe K, Yamazaki R, Hara T, Aoyagi A, Abe Y, Kaneko T.

Org Lett. 2002 Oct 3;4(20):3359-62.

PMID:
12323018
31.

[Development of overt hemolytic anemia after splenectomy for thrombocytopenia in Evans syndrome with negative Coombs test].

Nakamura Y, Arai Y, Nakamura F, Maki K, Aoyagi A, Saito K, Mitani K.

Rinsho Ketsueki. 2002 Mar;43(3):204-6. Japanese.

PMID:
11979754
33.

Spatial working memory is independent of hippocampal CA1 long-term potentiation in rats.

Kikusui T, Aoyagi A, Kaneko T.

Behav Neurosci. 2000 Aug;114(4):700-6.

PMID:
10959528
34.

Low-dose cytarabine and aclarubicin in combination with granulocyte colony-stimulating factor (CAG regimen) for previously treated patients with relapsed or primary resistant acute myelogenous leukemia (AML) and previously untreated elderly patients with AML, secondary AML, and refractory anemia with excess blasts in transformation.

Saito K, Nakamura Y, Aoyagi M, Waga K, Yamamoto K, Aoyagi A, Inoue F, Nakamura Y, Arai Y, Tadokoro J, Handa T, Tsurumi S, Arai H, Kawagoe Y, Gunnji H, Kitsukawa Y, Takahashi W, Furusawa S.

Int J Hematol. 2000 Apr;71(3):238-44.

PMID:
10846828
35.

[Case of diabetes mellitus with mitochondrial cardiomyopathy].

Shin I, Toyooka T, Yan I, Ueshino A, Kobayakawa T, Oniwa N, Aoyagi A, Sugiura K, Momomura S, Komata M.

Nihon Naika Gakkai Zasshi. 1999 Jul 10;88(7):1324-5. Japanese. No abstract available.

PMID:
10465982
36.

Isolation of Pythium Species from Zoysia Grass and Their Effect on Severity of Large Patch Disease.

Aoyagi A, Kageyama K, Hyakumachi M.

Plant Dis. 1999 Feb;83(2):171-175. doi: 10.1094/PDIS.1999.83.2.171.

PMID:
30849801
37.
38.

Reconstruction for palmar skin defects of the digits and hand using plantar dermal grafting.

Tanabe HY, Aoyagi A, Tai Y, Kiyokawa K, Inoue Y.

Plast Reconstr Surg. 1998 Apr;101(4):992-8.

PMID:
9514332
39.

[Results of the application of MTD to several types of specimens and the possibility of judging clinical courses based on MTD].

Ohsumi M, Toyota T, Kawashiro T, Aoyagi A.

Kekkaku. 1996 Dec;71(12):700-2. Japanese. No abstract available.

PMID:
9053543
40.
41.
42.
43.

Concurrent use of granulocyte colony-stimulating factor with low-dose cytosine arabinoside and aclarubicin for previously treated acute myelogenous leukemia: a pilot study.

Yamada K, Furusawa S, Saito K, Waga K, Koike T, Arimura H, Aoyagi A, Yamato H, Sakuma H, Tsunogake S, et al.

Leukemia. 1995 Jan;9(1):10-4.

PMID:
7531259
44.
45.
46.

[Reassessment of the clinical usefulness of Ga-67 citrate scanning in lung cancer using a log-likelihood-ratio method].

Kosuda S, Nishimura Y, Yanai N, Aoyagi A, Endo M, Takagi Y, Kubo A, Hashimoto S.

Kaku Igaku. 1983 Nov;20(9):1319-28. Japanese. No abstract available.

PMID:
6328070
47.

[FAB classification, response to therapy, and survival in adult patients with acute leukemia].

Moriyama Y, Aoki S, Urushiyama M, Ohnishi M, Hirosawa H, Koyama S, Hanano M, Fuse I, Takai K, Nagayama R, Fujiwara M, Kishi K, Takahashi M, Koike T, Sakai C, Kashimura M, Takahashi H, Miura R, Aoyagi A, Sanada M, Hattori A, Shibata A, Shinada S.

Rinsho Ketsueki. 1982 Nov;23(11):1706-12. Japanese. No abstract available.

PMID:
6962910
48.

[Therapeutic results of DCMP therapy (2M-80) in acute non-lymphocytic leukemia--the relationship between the residual leukemic cells and duration of remission].

Moriyama Y, Urushiyama M, Ohnishi M, Koyama S, Hirosawa H, Hanano M, Fuse I, Takai K, Nagayama R, Fujiwara M, Kishi K, Takahashi M, Koike T, Sakai C, Kashimura M, Miura R, Aoyagi A, Sanada M, Hattori A, Shibata A, Shinada S.

Gan To Kagaku Ryoho. 1982 Sep;9(9):1549-54. Japanese.

PMID:
6892201
49.

[Clinical studies on KW-1062 (author's transl)].

Mashimo K, Yamane Y, Yamaoka S, Yokoyama M, Hoshikawa K, Haneda Y, Hiraga Y, Takebe K, Imamura K, Yumita M, Okamura S, Hayashi I, Sekine O, Aoyagi A, Kikuchi K, Watanabe S, Kikuchi N, Kitamoto O, Kobayashi H, Miwa S, Kunii O, Fukaya K, Nakagawa K, Fujimori I, Obana M, Mitsui K, Takigami T, Takahashi I, Ohyama K, Takeda R, Kuroda M, Maekawa N, Nakanishi M, Kurimura O, Sasaki H, Tamaki K, Tokuomi H, Fukuda Y, Tokunaga K.

Kansenshogaku Zasshi. 1980 Mar;54(3):139-56. Japanese. No abstract available.

PMID:
6770011
50.

[Statistical investigation of crown and fixed partial denture prostheses (author's transl)].

Katoh T, Kagawa H, Tsukamoto K, Tejima R, Takigawa T, Aoyagi A, Murai N, Takehana S.

Aichi Gakuin Daigaku Shigakkai Shi. 1978 Sep;16(2):62-8. Japanese. No abstract available.

PMID:
389078

Supplemental Content

Loading ...
Support Center